Myriad Pharmaceuticals (NASDAQ: MYRX) today announced the company has entered into a definitive agreement to acquire Javelin Pharmaceuticals (AMEX: JAV) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE